Feb. 3, 2003 — Capital Stage, a Hamburg, Germany, equity investment company, will end its effort to create a nanotechnology-focused venture capital fund, according to a company news release.
Discussions with institutional and individual investors failed to raise sufficient funds for the Capital Stage Nanotech fund, the release said. Lack of economic improvement and low appetite for risk among investors were also cited as reasons for closing the fund.